LNC
BIIB icon

Lincoln National Corp’s Biogen BIIB Stock Holding History

Lincoln National Corp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,157
Closed -$249K – 127
2024
Q1 		$249K Sell
1,157
-55
-5% -$12.9K ﹤0.01% 1042
2023
Q4 		$314K Sell
1,212
-244
-17% -$59.9K 0.01% 856
2023
Q3 		$374K Sell
1,456
-8,363
-85% -$2.24M 0.01% 698
2023
Q2 		$2.8M Sell
9,819
-324
-3% -$96.4K 0.06% 191
2023
Q1 		$2.82M Buy
10,143
+1,743
+21% +$482K 0.06% 185
2022
Q4 		$2.33M Buy
+8,400
New +$2.37M 0.05% 202
2022
Q1 		– Sell
-1,121
Closed -$269K – 917
2021
Q4 		$269K Buy
1,121
+36
+3% +$9.26K 0.01% 755
2021
Q3 		$307K Sell
1,085
-1,920
-64% -$629K 0.01% 671
2021
Q2 		$1.04M Buy
3,005
+1,878
+167% +$569K 0.02% 311
2021
Q1 		$315K Sell
1,127
-318
-22% -$85.8K 0.01% 603
2020
Q4 		$354K Sell
1,445
-375
-21% -$96.7K 0.01% 526
2020
Q3 		$516K Buy
1,820
+254
+16% +$70.8K 0.02% 378
2020
Q2 		$419K Buy
1,566
+708
+83% +$213K 0.01% 410
2020
Q1 		$272K Buy
858
+3
+0.4% +$910 0.01% 469
2019
Q4 		$254K Buy
+855
New +$237K 0.01% 538
2019
Q3 		– Sell
-1,030
Closed -$241K – 582
2019
Q2 		$241K Sell
1,030
-99
-9% -$22.9K 0.01% 481
2019
Q1 		$267K Buy
+1,129
New +$356K 0.01% 412
2018
Q1 		– Sell
-962
Closed -$306K – 499
2017
Q4 		$306K Buy
+962
New +$309K 0.01% 492

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lincoln National Corp's BIIB Position: Q2 2024 in Review

Lincoln National Corp sold out of Biogen (BIIB) in Q2 2024, closing a stake of 1,157 shares — an estimated $249K sold.

Lincoln National Corp first reported a position in BIIB in Q4 2017 and held it in 18 quarters. The position peaked at $2.82M in Q1 2023. 944 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Lincoln National Corp reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 1,157 Biogen shares in Q2 2024, an estimated $249K.
  • Lincoln National Corp first reported a position in Biogen in Q4 2017 and held it in 18 quarters.
  • Lincoln National Corp's Biogen position peaked at $2.82M in Q1 2023.
  • 944 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.